Cold atmospheric plasma (CAP) is an electrically activated gas that operates near room temperature and produces a cocktail of reactive molecules capable of killing bacteria, triggering wound repair, and destroying cancer cells without burning tissue. Unlike the superheated plasma inside a welding torch or the sun, CAP stays cool enough to touch skin safely, which is what makes it medically useful. The technology sits at the intersection of physics, chemistry, and biology, and its range of applications has expanded rapidly over the past two decades.
What Plasma Actually Is
Plasma is sometimes called the fourth state of matter. When you push enough energy into a gas, electrons get stripped from their atoms, creating a soup of ions, free electrons, and neutral particles. Lightning and neon signs are everyday examples. Most plasmas are extremely hot, but cold atmospheric plasma is different. The electrons in CAP are energized to thousands of degrees, while the heavier ions and neutral gas molecules stay close to body temperature. Because those heavier particles are what you actually feel when plasma touches your skin, CAP feels barely warm.
To generate CAP, a device applies a high voltage across a flow of gas at normal atmospheric pressure. The two most common setups are plasma jets, which channel the gas through a nozzle to create a focused plume, and dielectric barrier discharge (DBD) devices, which use an insulating barrier between the electrodes. Working gases vary: helium, argon, nitrogen, and plain air are all used, sometimes mixed with small amounts of oxygen. The choice of gas and the power settings shape which reactive molecules the plasma produces and how deeply its effects penetrate.
The Reactive Species That Do the Work
CAP’s biological punch comes from the reactive oxygen and nitrogen species (RONS) it generates. When the energized electrons in the plasma collide with gas molecules and any moisture in the air, they break apart water and oxygen into highly reactive fragments. Short-lived species like hydroxyl radicals, superoxide, and singlet oxygen form in micromolar concentrations, while longer-lived molecules like hydrogen peroxide, nitric oxide, and nitrite-nitrate ions build up into the hundreds of micromolars.1PubMed Central. Analysis of reactive oxygen and nitrogen species generated in three liquid media by low temperature helium plasma jet These species are the same ones your immune cells naturally produce to fight infection, but CAP delivers them in a concentrated, controllable burst at a specific location.
When CAP is applied to a liquid, such as wound fluid or a water bath used for food decontamination, the reactive species dissolve into the liquid and create what researchers call plasma-activated water (or plasma-activated media). The concentrations of nitrite, nitrate, peroxynitrite, and hydrogen peroxide in that liquid depend heavily on the discharge type, gas mixture, and treatment time, which means practitioners can tune the chemistry for different purposes.2Journal of Physics D: Applied Physics. Reactive nitrogen species in plasma-activated water: generation, chemistry and application in agriculture The ability to adjust the recipe of reactive molecules is central to why CAP can be adapted for such different tasks, from sterilizing a wound to priming a seed for germination.
How CAP Damages Bacteria and Other Microbes
The antimicrobial action of CAP starts at the cell membrane. Reactive oxygen species, especially hydroxyl radicals and ozone, attack the unsaturated fatty acids in bacterial cell membranes. They pull hydrogen atoms from the carbon chains of those fats, triggering a chain reaction of lipid peroxidation that weakens the membrane and eventually tears it open.3PubMed Central. Effective Fungal Spore Inactivation with an Environmentally Friendly Approach Based on Atmospheric Pressure Air Plasma Hydrogen peroxide, another major product, penetrates through the damaged membrane and generates more hydroxyl radicals inside the cell, oxidizing DNA and proteins from within. The result is rapid cell death.
In lab studies, bacteria exposed to CAP from an argon-oxygen gas mixture were undetectable after five minutes of treatment. Gram-negative bacteria showed irreversible poration of their cell walls, while gram-positive bacteria shrank and collapsed.4Wiley Online Library. Dielectric barrier discharge cold atmospheric plasma: Bacterial inactivation mechanism Work on Salmonella typhimurium has shown that CAP dramatically shifts the ratio of unsaturated to saturated fatty acids in the membrane from about 0.31 down to 0.09, a clear sign of heavy oxidative damage.5PubMed Central. Evaluation of the Effects of Cold Plasma on Cell Membrane Lipids and Oxidative Injury of Salmonella typhimurium
CAP is also effective against biofilms, the stubborn, slime-encased colonies that make hospital-acquired infections so difficult to treat. A systematic review of in vitro studies on methicillin-resistant Staphylococcus aureus (MRSA) biofilms found that CAP reduced biofilm load by one to more than six orders of magnitude depending on exposure time and device settings, with several studies reporting near-complete eradication within minutes. Combining CAP with conventional antibiotics produced synergistic effects, meaning the two together worked better than either alone.6PubMed Central. Efficacy of Cold Atmospheric Plasma Against Methicillin‐Resistant Staphylococcus aureus Biofilms: A Systematic Review of In Vitro Studies For a healthcare system that is running out of effective antibiotics against resistant organisms, this combination strategy is one of the more promising angles CAP research has opened up.
Wound Healing, Especially Diabetic Foot Ulcers
Chronic wounds that refuse to heal, particularly diabetic foot ulcers, are one of the areas where CAP has the strongest clinical evidence. A randomized clinical trial compared standard wound care alone against standard care plus CAP treatment three times a week for three weeks. In the CAP group, roughly three-quarters of wounds shrank to half their original size or smaller, compared with about a third in the standard-care group. Patients receiving CAP were nearly six times more likely to achieve that level of wound reduction.7PubMed Central. Cold atmospheric plasma as an effective method to treat diabetic foot ulcers: A randomized clinical trial The treatment also produced an immediate drop in bacterial load at each session, though that antibacterial effect did not persist between visits.
Case reports extend the picture. One describes a 69-year-old man whose chronic diabetic foot ulcer had resisted every standard treatment for over a year, including advanced clinical trials. After switching to CAP therapy, the wound closed significantly over 15 weeks.8PubMed Central. Efficacy of Cold Atmospheric Plasma in Chronic Diabetic Foot Ulcer Management: A Case Report A single case report is not proof that CAP will work for everyone, but combined with the randomized trial data it paints a consistent picture: CAP accelerates tissue regeneration while simultaneously reducing the bacterial burden that often stalls healing in chronic wounds.9PubMed Central. Advancing chronic and acute wound healing with cold atmospheric plasma: cellular and molecular mechanisms, benefits, risks, and future directions
The mechanism behind the wound-healing benefit is layered. At lower doses, RONS act as signaling molecules that stimulate cell proliferation and migration, the basic building blocks of tissue repair. At higher doses, those same species kill bacteria and break apart biofilms. The trick is getting the dose right: too little and the antibacterial effect is weak, too much and you risk damaging healthy tissue. This dose-dependent duality is one reason treatment protocols are still being refined.
How CAP Affects Cancer Cells
The same oxidative stress that tears apart bacteria can also trigger programmed cell death in cancer cells. CAP has been shown to selectively induce apoptosis in cancer cells, reduce tumor volume, and inhibit metastasis in laboratory and animal studies.10PubMed Central. Cold Atmospheric Plasma: A Promising Controller of Cancer Cell States The selectivity seems to come from a basic difference between cancer cells and healthy ones: cancer cells already run at elevated levels of internal oxidative stress, so the additional burst from CAP pushes them over the threshold into cell death, while healthy cells, which start with more oxidative headroom, can absorb the hit and survive.
At the molecular level, CAP treatment of leukemia cells in one study led to a surge in intracellular reactive oxygen species, DNA damage, and activation of apoptotic pathways through both internal mitochondrial routes and external signaling. The cells attempted to compensate by ramping up their antioxidant enzymes, but the damage outpaced the defense.11PubMed Central. Cold Atmospheric Plasma Induces Apoptosis and Oxidative Stress Pathway Regulation in T-Lymphoblastoid Leukemia Cells Blocking the cell’s antioxidant response with a drug like sulfasalazine amplified the apoptosis further, and when an antioxidant (N-acetyl cysteine) was added, it dramatically reduced the CAP-induced cell death, confirming that the reactive oxygen species are doing the killing, not some other component of the plasma.12PubMed. Roles of intracellular and extracellular ROS formation in apoptosis induced by cold atmospheric helium plasma and X-irradiation in the presence of sulfasalazine
Beyond direct killing, CAP can provoke a form of cancer cell death called immunogenic cell death (ICD), in which the dying cancer cells release signals that attract and activate the immune system. In a melanoma mouse model, tumors treated with CAP showed a surge in cytotoxic T cells and reduced regulatory T cells, essentially converting the tumor from an immune-shielded fortress into a visible target. Combining CAP-induced ICD with cisplatin, a conventional chemotherapy drug, produced a synergistic anti-tumor effect that outperformed either treatment alone.13Journal of Physics D: Applied Physics. Immunogenic cell death induced by low temperature plasma to activate antitumor immunity and enhance therapeutic efficiency This opens the door to CAP as a component of combination cancer therapy, though clinical trials in humans are still in early stages.
Skin Conditions Beyond Wounds
Dermatology is emerging as a natural fit for CAP because the treatment can be applied directly and non-invasively to the skin surface. A review of the field describes CAP as demonstrating substantial antimicrobial properties and the ability to promote tissue proliferation, inhibit tumor cell migration, and do so with minimal side effects.14PubMed Central. Cold atmospheric plasma (CAP): a revolutionary approach in dermatology and skincare
One specific condition where preclinical results look promising is psoriasis. In an animal model, cold plasma reduced key inflammatory cytokines responsible for the thick, scaly plaques that characterize the disease. Treated mice showed measurable improvements in skin thickness, redness, and scaling.15PubMed Central. Cold Plasma Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Whether these results will translate from mice to patients remains an open question, but the anti-inflammatory mechanism is biologically plausible since the reactive species CAP delivers are known modulators of inflammatory signaling pathways.
CAP has also been explored as a way to improve transdermal drug delivery. A study using low-intensity CAP showed enhanced permeation of human epidermal growth factor through skin tissue, apparently by opening both the gaps between cells and pathways through the cells themselves.16Scientific Reports. Subcytotoxic transepidermal delivery using low intensity cold atmospheric plasma If confirmed in clinical settings, this could allow topical drugs that currently struggle to penetrate the skin barrier to reach therapeutic concentrations without injections.
Dentistry and Oral Health
Inside the mouth, CAP faces some of its most challenging targets: biofilms that colonize root canals, periodontal pockets, and the surfaces of dental implants. A systematic review found that CAP shows promise for root canal disinfection, treating periodontal and peri-implant diseases, managing caries, and even dental bleaching.17PubMed Central. Disinfection of dental root canals by cold atmospheric plasma: a systematic review and meta-analysis of dental biofilm
In one in vitro study, root canals infected with Enterococcus faecalis biofilm, a notoriously persistent bacterium in failed root canal treatments, were treated with cold plasma for varying durations. After eight to ten minutes of treatment, the antimicrobial effect was significantly greater than in untreated controls. Scanning electron microscopy showed ruptured bacterial membranes and fully destroyed biofilm architecture.18PubMed. Cold plasma therapy of a tooth root canal infected with enterococcus faecalis biofilms in vitro The advantage over conventional chemical irrigants like sodium hypochlorite is that CAP can reach crevices where liquid solutions cannot easily flow, and it does so without the toxicity concerns associated with strong chemical disinfectants.
CAP also modifies the surfaces of dental implants. Plasma treatment increases the surface energy and wettability of implant materials, which helps cells adhere and encourages early bone integration regardless of the implant’s original surface chemistry.19PubMed Central. Influence of cold atmospheric plasma on dental implant materials — an in vitro analysis Some dental offices already use handheld plasma devices to “activate” implant surfaces chairside, just before placement.
Food Safety and Agriculture
Outside the clinic, CAP has found a growing role in the food industry. The technology inactivates contaminating microorganisms on food and packaging surfaces, and it can also degrade pesticide residues and enzymes associated with spoilage.20PubMed Central. Cold plasma treatment advancements in food processing and impact on the physiochemical characteristics of food products Because CAP works at room temperature and does not require water or chemical sanitizers, it is attractive for fresh produce, meats, and ready-to-eat products where thermal processing would destroy texture and nutrients. The treatment is fast, typically seconds to a few minutes, and leaves no chemical residue on the food.
In agriculture, CAP has been tested as a seed treatment. Soybean seeds exposed to cold plasma at optimal durations of one to three minutes showed significant boosts in germination potential, root length, and seedling dry weight, along with increases in protective antioxidant enzyme activity.21PubMed Central. Evaluating the impact of Cold plasma on Seedling Growth properties, seed germination, and soybean antioxidant enzyme activity An earlier study found that plasma treatment at 80 watts produced the strongest stimulatory effect, with vigor indices jumping by over 60% and root dry weight increasing by roughly 28% compared with untreated seeds.22Scientific Reports. Effects of cold plasma treatment on seed germination and seedling growth of soybean The mechanism likely involves mild oxidative stress that “wakes up” the seed’s metabolic machinery and modifies the seed coat to allow better water uptake. Duration matters: too little treatment does nothing, and too much begins to damage the seed.
How Cells Respond at the Membrane Level
Understanding why CAP works across such different applications comes back to how its reactive species interact with cell membranes. Hydroxyl radicals penetrate to the phospholipid bilayer and cleave the phosphate head groups of membrane lipids, peroxidize the fatty acid tails, and reduce overall membrane thickness. The net effect is increased fluidity and permeability.23PubMed. Cold atmospheric plasma mediated cell membrane permeation and gene delivery-empirical interventions and pertinence This is not just a route to killing cells. At lower intensities, the temporary increase in permeability allows molecules that normally cannot cross the membrane, including therapeutic drugs and even DNA for gene therapy, to slip inside. CAP-induced transfection, getting genetic material into cells without a virus, is an active area of research for this reason.
The dose determines the outcome. A brief, gentle plasma exposure opens the membrane just enough for molecular cargo to enter, and the cell repairs itself afterward. A longer or more intense exposure overwhelms the membrane’s repair capacity, and the oxidative cascade spills into the cell’s interior, damaging mitochondria and DNA until the cell triggers its own death program. This single mechanism, scaled up or down, explains the seeming paradox that CAP can both heal tissue and destroy it.
Practical Limitations and Open Questions
For all its promise, CAP is not yet a plug-and-play technology in most clinical settings. One persistent challenge is standardization. Different devices, gas mixtures, flow rates, voltages, and treatment distances produce different concentrations of reactive species. A plasma jet running argon at three liters per minute with a two-centimeter treatment distance gives a very different dose profile than a DBD device running in ambient air. There is no universally accepted dosimetry system for CAP the way there is for, say, radiation therapy, and this makes it difficult to compare results across studies or to write treatment protocols that travel reliably from one clinic to another.
Measuring the reactive species themselves is another hurdle. Short-lived radicals vanish in microseconds, and the analytical methods used to detect them each have significant limitations and potential artifacts.24PubMed. Analysis of Short-Lived Reactive Species in Plasma-Air-Water Systems: The Dos and the Do Nots Until the field converges on reliable, standardized measurement techniques, the precise dose-response relationships for different tissues and pathogens will remain somewhat fuzzy. For wound care, regulatory approvals in Europe have moved ahead of those in the United States, with several CE-marked plasma devices already in clinical use for chronic wound management. FDA clearance for similar indications is still working through the pipeline.
Long-term safety data are also relatively thin. Short-term studies consistently report minimal side effects: mild warmth, occasional transient redness, and no systemic toxicity. But CAP is fundamentally an oxidative treatment, and the long-term effects of repeated oxidative stress on healthy tissue adjacent to the treatment site have not been followed over decades. For cancer applications, the field is even younger. The selectivity of CAP for cancer cells over healthy cells is well documented in cell culture and animal models, but translating that selectivity into human tumors with their complex microenvironments is a different challenge. Early-phase clinical trials are underway, but large, randomized human studies for cancer indications are still years away.